Janney Montgomery Scott’s Tango Therapeutics TNGX Stock Holding History

Janney Montgomery Scott’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.13M	Hold	36,000	–	–	﹤0.01%	1848
2026 Q1	$753K	Hold	36,000	–	–	﹤0.01%	1810
2025 Q4	$319K	Hold	36,000	–	–	﹤0.01%	2512
2025 Q3	$302K	Sell	36,000 -3,500	-9%	-$23.7K	﹤0.01%	2499
2025 Q2	$202K	Hold	39,500	–	–	﹤0.01%	2569
2025 Q1	$54K	Sell	39,500 -500	-1%	-$1.23K	﹤0.01%	2636
2024 Q4	$124K	Hold	40,000	–	–	﹤0.01%	2610
2024 Q3	$308K	Hold	40,000	–	–	﹤0.01%	2275
2024 Q2	$343K	Hold	40,000	–	–	﹤0.01%	2133
2024 Q1	$318K	Hold	40,000	–	–	﹤0.01%	2302
2023 Q4	$396K	Hold	40,000	–	–	﹤0.01%	2061
2023 Q3	$450K	Hold	40,000	–	–	﹤0.01%	1836
2023 Q2	$133K	Hold	40,000	–	–	﹤0.01%	2530
2023 Q1	$158K	Hold	40,000	–	–	﹤0.01%	2325
2022 Q4	$290K	Hold	40,000	–	–	﹤0.01%	2154
2022 Q3	$145K	Hold	40,000	–	–	﹤0.01%	2352
2022 Q2	$176K	Buy	+40,000	New	+$242K	﹤0.01%	2172
2022 Q1	–	Sell	-40,000	Closed	-$438K	–	2441
2021 Q4	$438K	Hold	40,000	–	–	﹤0.01%	1801
2021 Q3	$517K	Buy	+40,000	New	+$479K	﹤0.01%	1635

Other funds holding TNGX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Janney Montgomery Scott's TNGX Position: Q2 2026 in Review

Janney Montgomery Scott held its Tango Therapeutics (TNGX) position steady in Q2 2026 at 36,000 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1848.

Janney Montgomery Scott first reported a position in TNGX in Q3 2021 and has held it in 19 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

Janney Montgomery Scott held 36,000 shares of Tango Therapeutics worth $1.13M as of Q2 2026.
Janney Montgomery Scott left its Tango Therapeutics share count unchanged in Q2 2026.
Tango Therapeutics made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #1848 holding.
Janney Montgomery Scott first reported a position in Tango Therapeutics in Q3 2021 and has held it in 19 quarters since.
248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.